Patents by Inventor Ellis Reinherz

Ellis Reinherz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of identifying agents which enhance caspase activity
    Patent number: 7247438
    Abstract: Methods for identifying agents which enhance the activity of a caspase according to the invention are described, as well as methods for enhancing caspase activity and methods for enhancing apoptosis in a lymphocyte.
    Type: Grant
    Filed: October 9, 1997
    Date of Patent: July 24, 2007
    Assignee: Dana-Farber Cancer Institute
    Inventors: Ellis Reinherz, Linda Clayton, Timothy D. Ocain, Raymond J. Patch
  • Identification of the IkappaBNS protein and its products
    Publication number: 20050084916
    Abstract: The identification of a novel gene, termed I?BNS, regulated during negative selection of immature CD4+CD8+double positive (DP) thymocytes in mice, and the human homolog of the gene, are described, along with the gene products produced by these genes. Methods of using the disclosed genes and gene products are also described.
    Type: Application
    Filed: February 20, 2004
    Publication date: April 21, 2005
    Applicant: Dana-Farber Cancer Institute, Inc.
    Inventors: Ellis Reinherz, Linda Clayton, Emma Fiorini, Pedro Reche, Ingo Schmitz
  • Computer-based methods of designing molecules
    Publication number: 20050015232
    Abstract: The invention features a method of generating an immunogenic compound with the ability to induce an immune response to a molecule produced by a pathogenic agent, e.g., a infectious agent or a tumor cell. Also included in the invention are an immunogenic compound generated by the method of the invention and a method of inducing an immune response in a mammal that involves administering the immunogenic compound to the mammal.
    Type: Application
    Filed: August 8, 2002
    Publication date: January 20, 2005
    Inventors: Ellis Reinherz, Mikyung Kim, Pedro Reche, Jiahuai Wang
  • Recombinant DNA-produced T11 and fragments thereof
    Patent number: 5830754
    Abstract: A cDNA sequence encoding human T11 or a fragment thereof which is capable of inhibiting T-lymphocyte activation.
    Type: Grant
    Filed: December 21, 1994
    Date of Patent: November 3, 1998
    Assignee: Dana-Farber Cancer Institute
    Inventors: Ellis Reinherz, Peter Sayre, Hsiu-Ching Chang, Neil Richardson
  • Recombinant DNA-produced T11 and fragments thereof
    Patent number: 5608037
    Abstract: A cDNA sequence encoding human T11 or a fragment thereof which is capable of inhibiting T-lymphocyte activation.
    Type: Grant
    Filed: May 18, 1995
    Date of Patent: March 4, 1997
    Assignee: Dana Farber Cancer Institute
    Inventors: Ellis Reinherz, Peter Sayre, Hsiu-Ching Chang, Neil Richardson
  • Recombinant DNA-produced T11 and fragments thereof
    Patent number: 5550055
    Abstract: A cDNA sequence encoding human T11 or a fragment thereof which is capable of inhibiting T-lymphocyte activation.
    Type: Grant
    Filed: May 24, 1995
    Date of Patent: August 27, 1996
    Assignee: Dana-Farber Cancer Institute
    Inventors: Ellis Reinherz, Peter Sayre, Hsiu-Ching Chang, Neil Richardson